This trial is evaluating whether Treatment will improve 2 primary outcomes and 2 secondary outcomes in patients with Schizophrenia. Measurement will happen over the course of One day (in the Cigarette Discrimination Session), over a 6-hour time frame..
This trial requires 90 total participants across 0 different treatment group
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.